| 发明名称 |
Use of docetaxel for treating hepatoma |
| 摘要 |
The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 muM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
|
| 申请公布号 |
US2003158249(A1) |
申请公布日期 |
2003.08.21 |
| 申请号 |
US20020083565 |
申请日期 |
2002.02.27 |
| 申请人 |
AVENTIS PHARMA S.A. |
发明人 |
CHI CHIN-WEN;LIN HENG-LIANG;LIU TSUNG-YUN;LUI WING-YIU;CHAU GAR-YANG |
| 分类号 |
C07D305/14;A61K9/08;A61K31/00;A61K31/337;A61P1/16;A61P35/00;(IPC1-7):A61K31/337 |
主分类号 |
C07D305/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
